Martin Heidecker

Director, Investment Manager
Boehringer Ingelheim Venture Fund

Current Summit Page

Martin joined Boehringer Ingelheim Venture Fund in 2010 in Germany and moved to Boston, MA in 2013 to open US offices for the fund. He serves as board member of Tilos Therapeutics, Sentien Biotechnologies, Abexxa Biologics and Armagen, Inc.. Martin is board observer at Hookipa Pharma, Inc.

Martin is attending / has attended:

The 2017 New England Venture Summit
The 2016 New England Venture Summit
The 2015 New England Venture Summit
The 2019 New York Venture Summit

Join The Network!